[Federal Register Volume 87, Number 131 (Monday, July 11, 2022)]
[Notices]
[Page 41128]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-14713]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2022-0062]


Advisory Committee on Immunization Practices (ACIP); Amended 
Notice of Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment.

DATES: The meeting will be held on June 22, 2022, from 10:00 a.m. to 
5:10 p.m., EDT, and June 23, 2022, from 10:00 a.m. to 5:00 p.m., EDT 
(times subject to change). The docket is currently open to receive 
written comments. Written comments must be received on or before June 
23, 2022.

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Advisory Committee on Immunization Practices (ACIP); 
June 22, 2022, from 10:00 a.m. to 5:00 p.m., EDT, and June 23, 2022, 
from 10:00 a.m. to 2:00 p.m., EDT (times subject to change), in the 
original Federal Register notice.
    The virtual meeting was published in the Federal Register on 
Tuesday, May 10, 2022, Volume 87, Number 90, pages 28013-28014.
    The virtual meeting is being amended to change the times to June 
22, 2022, from 10:00 a.m. to 5:10 p.m., EDT, and June 23, 2022, from 
10:00 a.m. to 5:00 p.m., EDT (times subject to change), and to update 
the matters to be considered, which should read as follows:
    Matters To Be Considered: The agenda will include discussions on 
influenza vaccine; pneumococcal vaccines; measles, mumps, rubella (MMR) 
vaccine; COVID-19 vaccines; meningococcal vaccines; respiratory 
syncytial virus vaccine; Chikungunya vaccines; and human papillomavirus 
vaccine. Recommendation votes on influenza vaccine, pneumococcal 
vaccine, MMR vaccine, and the use of Moderna COVID-19 vaccine in 
children ages 6 through 17 years are scheduled. A Vaccines for Children 
vote(s) is scheduled on pneumococcal vaccine and is possible on MMR 
vaccine. Agenda items are subject to change as priorities dictate. For 
more information on the meeting agenda, visit https://www.cdc.gov/vaccines/acip/meetings/index.html. The meeting will be webcast live via 
the World Wide Web; for more information on ACIP, visit the ACIP 
website: https://www.cdc.gov/vaccines/acip/index.html.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, Mailstop H24-8, Atlanta, Georgia 30329-4027; Telephone: 404-
639-8367; Email: <a href="/cdn-cgi/l/email-protection#85c4c6ccd5c5e6e1e6abe2eaf3"><span class="__cf_email__" data-cfemail="87c6c4ced7c7e4e3e4a9e0e8f1">[email protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-14713 Filed 7-8-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>